Viewing Study NCT05233332


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-01 @ 1:05 PM
Study NCT ID: NCT05233332
Status: UNKNOWN
Last Update Posted: 2023-05-31
First Post: 2022-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC)
Sponsor: Shanghai Kechow Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CRC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic colorectal cancer (mCRC) View
None HL-085 View
None Vemurafenib View